Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Aug;19(8):102597.
doi: 10.1016/j.autrev.2020.102597. Epub 2020 Jun 11.

Covid-19 and autoimmunity

Michael Ehrenfeld  1 , Angela Tincani  2 , Laura Andreoli  3 , Marco Cattalini  4 , Assaf Greenbaum  5 , Darja Kanduc  6 , Jaume Alijotas-Reig  7 , Vsevolod Zinserling  8 , Natalia Semenova  8 , Howard Amital  9 , Yehuda Shoenfeld  10
Affiliations
Review

Covid-19 and autoimmunity

Michael Ehrenfeld et al. Autoimmun Rev. 2020 Aug.
No abstract available

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Infiltration by CD8+ suppressor T-cells of different organs. IHC. Magnification 100. A-Lungs, B -Adrenal gland, C-liver, D- intestine.
See this image and copyright information in PMC

References

    1. Shoenfeld Y., Isenberg D.A. Elsevier; Holland: 1989. The mosaic of autoimmunity. [p.523] - PubMed
    1. Amital H., Gershwin E.M., Shoenfeld Y. Reshaping the mosaic of autoimmunity. Semin Arthritis Rheum. 2006;35:341–343. - PubMed
    1. Buskila D., Sikuler E., Shoenfeld Y. Hepatitis C virus, autoimmunity and rheumatic disease. Lupus. 1997;6:685–690. - PubMed
    1. Cohen A., Shoenfeld Y. The viral autoimmunity relationship. Viral Immunol. 1995;8:1–9. - PubMed
    1. Barzilai O., Ram M., Shoenfeld Y. Viral infection can induce the production of autoantibodies. Curr Opin Rheumatol. 2007;19:636–643. - PubMed

Addendum: Following this submission the enclosed references were published (129–143).

    1. Colafrancesco S., Alessandri C., Conti F. COVID-19 gone bad: A new character in the spectrum of hyperferritinemic syndrome? Autoimun Rev. 2020 doi: 10.1016/j.autrev.2020.102573. - DOI - PMC - PubMed
    1. Alijotas-Reig J., Esteve-Valverde E., Belizna C. Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review. Autoimmun Rev. 2020 doi: 10.1016/j.autrev.2020.102569. - DOI - PMC - PubMed
    1. Segal G., Mevorach D., Elis A. Clinical Insights and Management Recommendations for COVID-19 Patients Hospitalized in Internal Medicine Departments: Recommendations by the Corona Department Heads in Israel. Isr Med Assoc J. 2020;22:275–277. - PubMed
    1. Itelman E., Wasserstrum Y., Segev A. Clinical Characterization of 162 COVID-19 patients in Israel: Preliminary Report from a Large Tertiary Center. Isr Med Assoc J. 2020;22:271–274. - PubMed
    1. Jamilloux Y., Henry T., Belot A. Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions. Autoimmune Rev. 2020 doi: 10.1016/j.autrev.2020.102567. - DOI - PMC - PubMed